Ignite Creation Date:
2024-05-06 @ 6:05 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05546268
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2022-09-16
Brief Title:
Study of Oral MRT-2359 in Selected Cancer Patients
Sponsor:
Monte Rosa Therapeutics Inc
Organization:
Monte Rosa Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| NSCLC |
| SCLC |
| High Grade Neuroendocrine Cancer |
| DLBCL |
| L-MYC and N-MYC Amplified Solid Tumors |
| NSCLC With High or Low L-MYC or N-MYC Expression |
| HR-positive HER2-negative Breast Cancer |
| Prostate Cancer |
Keywords:
| Name | View |
|---|---|
| Prostate Cancer | View |
| Small Cell Lung Cancer | View |
| Non-Small Cell Lung Cancer | View |
| L-MYC Amplification | View |
| N-MYC Amplification | View |
| L-MYC expression | View |
| N-MYC expression | View |
| High-grade neuroendocrine | View |
| Diffuse Large B-Cell Lymphoma | View |
| Molecular glue degrader | View |
| Anti-tumor | View |
| GSPT1 | View |
| HR-positive | View |
| HER2-negative | View |
| Breast Cancer | View |